Ignite Creation Date:
2024-05-05 @ 5:28 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00464893
Status:
COMPLETED
Last Update Posted:
2013-12-04
First Post:
2007-04-23
Brief Title:
Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection
Sponsor:
Neovii Biotech
Organization:
Neovii Biotech
Organization Data
Organization:
Neovii Biotech
Class:
INDUSTRY
Study ID:
IP-CAT-GC-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Neovii Biotech
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None